Skip to main content
Screener/Healthcare/Drug Manufacturers - Specialty & Generic

ORGO Organogenesis Holdings Inc.

NASDAQ
$2.37-0.16 (-6.32%)
$2.04
$7.08
$2.04
$2.46
EPS (TTM)$-0.16
P/E Ratio22.45
Dividend Yield
Market Cap$333.2M
Volume2.67M
Prev Close$2.53
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$37.2M-$56.2M$-0.440.0%-150.9%
Q4 '25$225.6M$43.7M$0.2774.8%19.4%
Q3 '25$150.9M$21.6M$0.1176.0%14.3%
Q2 '25$100.8M-$9.4M$-0.1072.6%-9.3%
Q1 '25$86.7M-$18.8M$-0.1772.6%-21.7%
Q4 '24$126.7M$7.7M$0.0475.5%6.1%
Q3 '24$115.2M$12.3M$0.0976.7%10.7%
Q2 '24$130.2M-$17.0M$-0.1377.6%-13.1%
Get Your Daily Market Recap